Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab

NCT00139841

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • Tower Hematology and Oncology Medical Group Beverly Hills, California, United States
View all 40 locations
View Trial Details
Completed

Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma

NCT00069758

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Comprehensive Cancer Center-Desert Regional Medical Center Palm Springs, California, United States
  • San Diego Cancer Center Vista, California, United States
  • Georgetown University Medical Center - Lombardi Cancer Center Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma

NCT00743288

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • James R. Berenson MD, Incorporated West Hollywood, California, United States
  • Rocky Mountain Cancer Centers - Denver Midtown Denver, Colorado, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
View Trial Details

Related conditions